| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.33 | 0.09 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |